aberrations and suit enough to tolerate FCR therapy, should still be great candidates with the latter, Along with the advantage remaining that this procedure could be concluded in 6 months when ibrutinib should be taken indefinitely. Dilisensikan di tiga yurisdiksi—Gibraltar, Μalta, dan